A detailed case can raise a research question without answering whether an intervention works generally. This early DSIP publication concerns one person. Primary study
What was studied
A 35-year-old man with narcolepsy received repeated DSIP injections. The report described fewer sleep attacks, improved daytime alertness and performance, and altered nighttime sleep measures. Assessment included self-report, performance testing, multiple sleep latency testing, and overnight polysomnography. There was no randomized comparison group. Primary report
Our appraisal: more measurements do not create more participants
Multiple types of assessment can make a case description richer. They can show whether observations align across subjective experience and laboratory measurements. They do not, however, transform one person into a controlled clinical trial or provide independent replication.
Without a suitable comparison, improvement can have several explanations. Symptoms may fluctuate, expectations can change reporting, and other care or behavior may change alongside the intervention. These are alternative possibilities to evaluate, not accusations about what happened in this particular case.
The treatment's name also should not dictate the interpretation. A report of improved daytime wakefulness is a different claim from one about increasing nighttime sleep. A peptide discussed in sleep research should not be assumed to produce the same effect in every disorder or at every time of day.
Generalizing requires evidence in additional participants with clear diagnostic criteria, appropriate comparators, and clinically meaningful outcomes. Safety needs separate attention because a single case cannot characterize uncommon adverse effects or the consequences of prolonged exposure.
This paper is best treated as a historical hypothesis-generating observation. It does not establish DSIP as a narcolepsy treatment, prove a circadian mechanism, or provide a basis for replacing established care. Its apparent positive findings should remain explicitly attached to the single-patient design.
Frequently asked questions
How many patients were described?
One.
Were objective sleep assessments included?
Yes.
Was there a randomized control group?
No.
Do several tests equal independent replication?
No.
Was a circadian mechanism proven?
No, it was an interpretation proposed from the observations.
Does this establish general efficacy or safety?
No.
What is the report's role?
Generating a question for controlled research.